The FDA began two days of meetings about a controversial procedure that removes a mother's nucleus from her egg, leaving behind defective genes, and places it in a donor egg
The FDA began two days of meetings about a controversial procedure that removes a mother's nucleus from her egg, leaving behind defective genes, and places it in a donor egg. The procedure aims to prevent children from inheriting diseases, but as Dr. Jon LaPook reports, critics have raised concerns.
